These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28233446)

  • 1. Development of de novo psoriasis during nivolumab therapy for metastatic renal cell carcinoma: immunohistochemical analyses and clinical outcome.
    Ruiz-Bañobre J; Abdulkader I; Anido U; León L; López-López R; García-González J
    APMIS; 2017 Mar; 125(3):259-263. PubMed ID: 28233446
    [No Abstract]   [Full Text] [Related]  

  • 2. Fulminant acneiform eruptions after administration of dovitinib in a patient with renal cell carcinoma.
    Hsiao YW; Lin YC; Hui RC; Yang CH
    J Clin Oncol; 2011 Apr; 29(12):e340-1. PubMed ID: 21263088
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-pigmenting fixed drug eruption induced by sorafenib.
    Tanabe K; Amoh Y; Mii S; Eto H; Iwamura M; Katsuoka K
    Acta Derm Venereol; 2010 May; 90(3):307. PubMed ID: 20526556
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Multifocal Renal Cell Carcinoma in a Solitary Kidney With Nivolumab.
    Shinder B; Farber NJ; Mayer T; Singer EA
    Clin Genitourin Cancer; 2017 Feb; 15(1):e165-e167. PubMed ID: 27396730
    [No Abstract]   [Full Text] [Related]  

  • 5. Nivolumab-Induced Development of Pulmonary Sarcoidosis in Renal Cell Carcinoma.
    Zhang M; Schembri G
    Clin Nucl Med; 2017 Sep; 42(9):728-729. PubMed ID: 28737580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments.
    Seneschal J; Milpied B; Vergier B; Lepreux S; Schaeverbeke T; Taïeb A
    Br J Dermatol; 2009 Nov; 161(5):1081-8. PubMed ID: 19681863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flare of pustular psoriasis after initiating ustekinumab therapy.
    Wenk KS; Claros JM; Ehrlich A
    J Dermatolog Treat; 2012 Jun; 23(3):212-4. PubMed ID: 21254881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efalizumab-associated papular psoriasis: an adverse reaction to efalizumab in three cases.
    Antonucci A; Bardazzi F; Balestri R; Patrizi A
    J Dermatolog Treat; 2009; 20(1):61-2. PubMed ID: 18618361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Papulopustular Rosacea during Nivolumab Therapy for Metastatic Cancer.
    Bousquet E; Zarbo A; Tournier E; Chevreau C; Mazieres J; Lacouture ME; Sibaud V
    Acta Derm Venereol; 2017 Apr; 97(4):539-540. PubMed ID: 27826614
    [No Abstract]   [Full Text] [Related]  

  • 10. Transition of psoriasiform drug eruption to psoriasis de novo evidenced by histopathology.
    Yamamoto M; Ikeda M; Kodama H; Sano S
    J Dermatol; 2008 Nov; 35(11):732-6. PubMed ID: 19120769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eruptive keratoacanthomas secondary to nivolumab immunotherapy.
    Bednarek R; Marks K; Lin G
    Int J Dermatol; 2018 Mar; 57(3):e28-e29. PubMed ID: 29318617
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurring cutaneous eruption in a patient with metastatic renal cell carcinoma being treated with high-dose interleukin 2.
    O'Reilly F; Feldman E; Yang J; Hwu P; Turner ML
    J Am Acad Dermatol; 2003 Apr; 48(4):602-4. PubMed ID: 12664026
    [No Abstract]   [Full Text] [Related]  

  • 13. Intracorneal pustular drug eruption associated with nivolumab in a patient with metastatic renal cancer.
    Deinlein T; Kränke B; Cerroni L; Weger W
    Int J Dermatol; 2020 Dec; 59(12):e435-e437. PubMed ID: 32864767
    [No Abstract]   [Full Text] [Related]  

  • 14. [Initially undetected de novo psoriasis triggered by nivolumab for metastatic base of the tongue carcinoma].
    Troyanova-Slavkova S; Eickenscheidt L; Dumann K; Kowalzick L
    Hautarzt; 2018 Aug; 69(8):674-680. PubMed ID: 29330579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of pustular psoriasis after treatment of Crohn disease with infliximab.
    Pourciau C; Shwayder T
    Pediatr Dermatol; 2010; 27(5):539-40. PubMed ID: 20796241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of Psoriasiform Eruption During Nivolumab Therapy for Primary Oral Mucosal Melanoma.
    Ohtsuka M; Miura T; Mori T; Ishikawa M; Yamamoto T
    JAMA Dermatol; 2015 Jul; 151(7):797-9. PubMed ID: 25875052
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinoma.
    Farolfi A; Schepisi G; Conteduca V; Burgio SL; Lolli C; De Giorgi U
    Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1089-96. PubMed ID: 27450183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer.
    Rowinsky EK; Schwartz GH; Gollob JA; Thompson JA; Vogelzang NJ; Figlin R; Bukowski R; Haas N; Lockbaum P; Li YP; Arends R; Foon KA; Schwab G; Dutcher J
    J Clin Oncol; 2004 Aug; 22(15):3003-15. PubMed ID: 15210739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of untreated local advanced or metastatic renal cell carcinoma. Phase III, randomized, open-label study of nivolumab combined with ipilimumab versus sunitinib monotherapy in subjects with previously untreated, local advanced or metastatic renal cell carcinoma (CheckMate 214 - AN 36/15 of the AUO)].
    Rexer H
    Urologe A; 2015 Oct; 54(10):1443-5. PubMed ID: 26350358
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement of psoriasis during sunitinib therapy for renal cell carcinoma.
    Narayanan S; Callis-Duffin K; Batten J; Agarwal N
    Am J Med Sci; 2010 Jun; 339(6):580-1. PubMed ID: 20421784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.